StockData
MDNYSEServices-HospitalsFiscal year ends December 31

Pediatrix Medical Group, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$27.30−0.08 (-0.29%)

Close on Oct 19, 2026

Market cap
$2.22B
P/E (TTM)
13.1
Dividend yield
–

Pediatrix Medical Group, Inc. revenue by segment

By business segment

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016% of revenueYoY
Net patient service revenue [Member]$1.63B$1.72B$1.72B$1.69B$1.64B$1.48B$1.57B$1.53B$2.92B$2.76B85.2%-5.4%
Hospital contract administrative fees [Member]$271.13M$286.68M$275.68M$262.93M$240.02M$218.50M$197.34M$181.05M$315.78M$271.89M14.2%-5.4%
Other revenue [Member]$12.21M$2.63M$2.60M$20.27M$29.85M$34.13M$14.80M$12.50M$21.97M–0.6%+364.0%
Management Services [Member]–––––––$215.97M$226.89M$151.08M––

By region

From the segment and revenue-disaggregation notes of Pediatrix Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.